tangles disrupt cells ability communicate trigger forms damage inflammation tau involved ad abnormalities different protein amyloid beta thought initial trigger chain biological events including tau pathology underlies neurodegeneration ad drugs developed date targeted amyloid tau received increasing attention multiple drugs intended remove amyloid failed published wednesday suggests existing drug lonafarnib repurposed treat neurodegenerative diseases involve tau team researchers led neuroscientist kenneth kosik university california santa barbara found drug beneficial effects tau related pathology mice administered early extended period found evidence suggesting works previously unknown biological mechanism opens previously completely unsuspected pathway tau degradation says kosik longtime tau researcher not molecular